In 1993, Malawi became the first African country to replace chloroquine with sulfadoxine-pyrimethamine
nationwide in response to high rates of chloroquine-resistant falciparum malaria…

Background Blood-stage malaria vaccines are intended to prevent clinical disease. The
malaria vaccine FMP2.1/AS02 A , a recombinant protein based on apical membrane antigen 1 (…

Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that have …

… (B) Resistance to KA was associated with high levels of both IL-22 and IL-17, whereas KA
was associated with low levels of these cytokines. IL-17 and IL-22 levels were each assigned …

… In addition, phenotypic analysis of the B-cell compartment by flow cytometry has shown that
the malaria-resistant Fulani tend to have a higher percentage of activated memory B cells (…

… no association between the allele and the phenotype (Kouriba et al., manuscript submitted).
… markedly in this population in all age classes (Kouriba et al., manuscript in preparation) (Fig…

Good data on background seroprevalence of major transfusion transmitted infections is lacking
in Mali. We gathered data on the rate of positive donations of human immunodeficiency …

Background Modelling malaria parasitaemia as function of fever has been proposed as best
alternative to estimate the attributable fraction of malaria fever and the sensitivity and …

… Subgroup B is including subjects with either no or mild fibrosis. The final subgroup (C) is …
FIII (subgroup C) with F0 + FI subjects (subgroup B). The result of this analysis supported the …

Background The recent decline in malaria incidence in many African countries has been
attributed to the provision of prompt and effective anti-malarial treatment using artemisinin-…